Introduction
Various studies have shown a defective cell mediated immune system in patients with chronic warts.' 2 B cell activity in the form ofIgG complement fixing antibody has been reported to be associated with regression of warts.34 The conventional treatment, which is available, is not universally satisfactory. Various alternative methods of treatment have been used to stimulate the immune system and produce a permanent cure. An antihelminthic, levamisole, was found to restore the cutaneous delayed hypersensitivity in anergic patients with cancer.5 In one study levamisole produced a cure rate of 90% in patients with common warts.6 A subsequent double blind study, however, showed that levamisole was no more effective than placebo.7 This drug has also become unpopular because of adverse reactions. 8 Recently, a relatively safe immunomodulator, inosine pranobex (Imunovir, Edwin Burgess Limited), was introduced in the United Kingdom for the treatment of mucocutaneous herpes simplex virus infection. 9 We decided to include inosine pranobex in a prospective study on 
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In this open study we found that inosine pranobex cured 39% of patients treated. This success rate does not differ significantly from that achieved with podophyllin orcryotherapy and does notjustify the use of inosine pranobex alone for treating gential warts.
Overall, conventional treatment achieved a success rate of only 41%. This was mainly due to the large number ofpatients given podophyllin. Podophyllin has already been reported as giving a poor response." In our hands cryotherapy cured 59% ofpatients, a similar success rate to that reported elsewhere. '2 The observation that conventional treatment was particularly effective in patients whose warts had been diagnosed recently, whereas inosine pranobex proved more successful in lesions of longer duration, was interesting. The apparently lower efficacy of conventional treatment (primarily podophyllin) in warts of a longer duration may be a reflection of the previous failure of conventional treatment The natural history ofgenital warts is unpredictable, and a considerable number of patients will show spontaneous regression. Nevertheless, the results of this study and others reported elsewhere'5 16 show a positive role for inosine pranobex in the management of such cases. Further trials, including double blind placebo controlled studies, are justified. It will also be valuable to monitor the effect of the drug on the local immune response of HPV lesions.
